By Jefferey Jaxen

According to their now-preferred method of scientific communication, the U.S. Food and Drug Administration’s (FDA) press release has recently dictated to the medical community and public at large that it has authorized a second booster dose of both Moderna and Pfizer COVID shots for various groups and ages.

The agency has now amended its Emergency Use Authorization (EUA) to include a second booster dose of Moderna or Pfizer for 50 years of age and older at least 4 months after a first booster dose, a second dose of Pfizer for individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after a first booster dose, and a second dose of Moderna 4 months after the first booster dose for 18 years of age and older who are immunocompromised.

This was all done without convening its expert voting committee adding further division and contention among the medical and scientific community. It was exactly the agency’s [first] expedited booster push, sans robust data, in August of 2021 that led two senior scientists to resign in protest.

The FDA appears to have adopted Plotkin’s commandment in stride by incorporating the wordplay into its latest press release by stating:

The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization and death.

In case you have lost count, the FDA’s new vaccine edicts gives the green light to shots/boosters four and five.

No one was speaking about a 3-shot series until after August 30, 2021 – the date of a CDC advisory committee meeting in which Stanely Plotkin called in to make a comment and effect vaccine policy – or as StatNews stated reported at the time ‘when Stanley Plotkin speaks, people listen.’

Calling the third dose a booster is immunologically incorrect and also gives the wrong impression that somehow the vaccines failed…” stated Plotkin.

So if you are immunocompromised, two shots plus a (third) booster is your primary series and the added (forth) booster previously meant you fell under the ‘fully vaccinated’ definition. Now, today’s FDA decision makes a second (fifth) booster available, which, minus the medical doublespeak, would be the fifth shot being injected into your arm presumably making you fully vaccinated once again.

Rather than being transparent and linking to the data the FDA used to inform their decision, the press release gave a basic summary. For safety, the FDA relied on open population surveillance imported from Israel’s Ministry of Health along with one study of 120 people. For immunogenicity data, the FDA looked at a publication provided to them from an ongoing study in healthcare workers at a single center in Israel.

In Janurary 2022, The Financial Times reported about the dismal findings of an Israeli study at the Sheba Medical Center writing:

Healthcare workers at the Sheba Medical Center who received a fourth dose of the vaccine continued to get infected even though blood tests showed an increase in two key kinds of antibodies, according to professor Gili Regev-Yochay who led the research.

Enough of them tested positive for coronavirus two weeks after their fourth jabs to indicate that the level of antibodies needed to protect against infection from Omicron was “probably too high” for the vaccine to induce, said Regev-Yochay.

Moving into the vote, professor of epidemiology and biostatistics at the University of California, San Francisco Vinay Prasad observed that the FDA vaccine regulation was sliding further into the abyss by writingIf the FDA moves forward on authorizing either product, it will cement a dangerous precedent: inadequate evidence being used to justify widespread vaccination for years to come.”

Meanwhile, Johns Hopkins Marty Makary, M.D. took to Twitter for a series of comments:

The U.K. appears to be heading in the same direction with its Health Minister Sajid Javid recently saying it was ‘possible’ there would be an autumn booster ‘probably for those that are 50 and over.’ Currently in the U.K., over-75 year olds, care home residents and patients with weak immune systems are receiving invitations for a spring boosters.

If they are offered another jab in the autumn, it will be their fifth. Some immunocompromised adults will have already had five by then according to a Daily Mail report.

Jefferey Jaxen

Jefferey Jaxen is a health journalist and featured in his weekly segment, ’The Jaxen Report’, on The HighWire. As an investigative journalist, researcher, and compelling writer, Jefferey serves as Lead editor of The HighWire News and Opinion Team.

Other Headlines

Coronavirus

Former Governor Cuomo Questioned in COVID Hearing Over Nursing Home Policy Linked to 15,000 Deaths

Former New York Governor Andrew Cuomo testified in front of the Select Subcommittee on the Coronavirus Pandemic on Tuesday to discuss his role in the deaths of elderly residents at nursing home facilities during the pandemic. Chairman Brad Wenstrup called the hearing and said the focus was on Cuomo’s March 25 directive that required nursingContinue reading Former Governor Cuomo Questioned in COVID Hearing Over Nursing Home Policy Linked to 15,000 Deaths

More news about Coronavirus

Health & Nutrition

Water Fluoridation Battle Heats Up Despite Federal Court Ruling

Following the landmark federal court victory by the Fluoride Action Network against the EPA, several towns and cities have begun the process of stopping the addition of fluoride to the community water supply. Dental associations, meanwhile, have doubled down on their support for the neurotoxic chemical linked with reduced IQ in children. The American DentalContinue reading Water Fluoridation Battle Heats Up Despite Federal Court Ruling

More news about Health & Nutrition

Vaccines

FDA Approves Smallpox Vaccine for Monkeypox Despite High Transmission Risk

The FDA approved a vaccine (ACAM2000) in August for monkeypox despite the high risk of virus transmission from the vaccinated individual to others. The vaccine insert states, “Death has also been reported in unvaccinated contacts accidentally infected by individuals who have been vaccinated.” The vaccine has been approved for smallpox since 2007 and the CDCContinue reading FDA Approves Smallpox Vaccine for Monkeypox Despite High Transmission Risk

More news about Vaccines

Science & Tech

USDA Reopens Comment Period for Deregulation of Gene-Edited Plants

The deregulation of gene-edited plants is on the USDA agenda, and the public comment period has been extended by 21 days. The comment page has yet to be posted on the Federal Register. CRISPR is a new technology that is being used in agriculture to modify plants. “New Gene Technologies” or NGTs are how big agricultural companies like Bayer areContinue reading USDA Reopens Comment Period for Deregulation of Gene-Edited Plants

More news about Science & Tech

Environment

Hurricane Helene Death Toll Far Higher Than Reported, Says Expert

As disaster response continues in the devastating aftermath of Hurricane Helene, a disaster management expert on the ground says there are 250 confirmed deaths in just one single county. Steve Slepcevic appeared on The HighWire to give an update into the disaster recovery and medical aid response from the Hickory airport in North Carolina. Recent reportsContinue reading Hurricane Helene Death Toll Far Higher Than Reported, Says Expert

More news about Environment

Policy

FDA Reorganizes Agency To “Enhance Transparency And Trust”

The FDA has officially created the unified Human Foods Program as part of a larger restructuring effort that the agency says will help to “effectively deliver on our mission to protect and promote public health through science-based approaches to prevent foodborne illness, reduce diet-related chronic disease, and ensure the safety of chemicals in our food.”Continue reading FDA Reorganizes Agency To “Enhance Transparency And Trust”

More news about Policy